Donate Contact Us Events Donate Contact Us Events

Text Only | Macular Degeneration | Retinitis Pigmentosa | Usher | Stargardt | Other Retinal Diseases
Foundation Fighting Blindness HomepageMacular Degeneration - Meet the Kelly FamilyDonate for research on Macular Degeneration, Retinitis Pigmentosa, Usher Syndrome, Stargardt Disease and Other Retinal Degenerative Diseases
Science and Research
Treatments & Cures
Clinical Trials
Coping Resources
Featured Stories
Messages and Chat
About Us
Get Involved
Publications
Local Community
Press Room
Viewing This Site
Donate

Speaker Icon Microsoft WebSpeak has been installed to read content on this site aloud. When you see this speaker icon, use your mouse to click on it and the wizard will be activated.

Email Newsletter
Sign up here for the latest research and science news, and FDA-approved clinical trials related to retinal degenerative diseases.
Driving research to save and restore sight.
Login     Register & Benefit

Macular Degeneration

Macular degeneration is a group of diseases characterized by a breakdown of the macula. The macula is the center portion of the retina that makes central vision and visual acuity possible.

Age related macular degeneration (AMD) is a retinal degenerative disease that causes progressive loss of central vision. The risk of developing macular degeneration increases with age. The disease most often affects people in their sixties and seventies. Macular degenerationis the most common cause of vision loss in individuals over the age of fifty-five.

Clinical Description
Central vision loss from macular degeneration occurs when photoreceptor cells in the macula degenerate. The macula is the central portion of the retina responsible for perceiving fine visual detail. Light sensing cells in the macula, known as photoreceptors, convert light into electrical impulses and then transfer these impulses to the brain via the optic nerve.

Individuals with macular degeneration may first notice a blurring of central vision that is most apparent when performing visually detailed tasks such as reading and sewing. As the disease progresses, blind spots form within central vision. In most cases, if one eye has macular degeneration, the other eye will also develop the disease. The extent of central vision loss varies according to the type of macular degeneration.

There are two types of macular degeneration: dry and wet. Dry macular degeneration accounts for about 90 percent of all cases. Dry macular degeneration is sometimes called atrophic, nonexudative, or drusenoid macular degeneration. With dry macular degeneration, yellow-white deposits called drusen accumulate in the retinal pigment epithelium (RPE) tissue beneath the macula. Drusen deposits are composed of waste products from photoreceptor cells.

Wet macular degeneration accounts for about 10 percent of cases. Wet macular degeneration is also called choroidal neovascularization, subretinal neovascularization, exudative, or disciform degeneration. In wet macular degeneration, abnormal blood vessel growth forms beneath the macula. These vessels leak blood and fluid into the macula damaging photoreceptor cells. Wet macular degeneration tends to progress rapidly and can cause severe damage to central vision.

In some cases, if wet macular degeneration is diagnosed early, laser surgery can prevent extensive central vision loss. In this type of surgery, laser beams destroy the leaky blood vessels that form beneath the macula. For laser surgery to be effective, it is critical that macular degeneration be diagnosed before extensive vision loss occurs. If you are diagnosed with wet macular degeneration, you may want to ask your doctor about these treatments.

Treatments
Recently, there has been considerable progress in developing for treatments for macular degeneration. These treatments include laser photocoagulation, photodynamic therapy, antioxidant and zinc therapy.

Find out more about new treatments for macular degeneration.



Bobby WorldWide Approved A


Viewing This Site | Home | Text Only Version | Site Map | Privacy Statement | Back to Top

This site is funded in part by:
W.K. Kellogg   American Legion Child Welfare Foundation, Inc.

©2007 Foundation Fighting Blindness. All rights reserved.